Login
Super Investors Fidelity Small Cap Growth Fund

Fidelity Small Cap Growth Fund

Fidelity Securities Fund · net assets $8.8B · 365 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 93.2% · STIV: 5.7% · EP: 1.0% · DBT: 0.0%

Financial position

Total assets
$9.21B
Total liabilities
$414M
Net assets
$8.8B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$27.3M
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$312K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $52.2M $57.5M $50.6M
Reinvestment $0 $590 $-0.03
Redemptions $85.2M $97.8M $82.3M
Net realized gain (non-derivative) $157M $692M $426M
Net unrealized appreciation (non-derivative) $243M $-50.1M $-980M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
Fidelity Securities Fund
Registrant CIK
754510
Registrant LEI
LIUMB3NDWOFJPXVROE85
Series
Fidelity Small Cap Growth Fund
Series ID
S000007193
Series LEI
6LBIT89H3QBQP5S24W88
SEC file number
811-04118
Address
245 Summer Street, Boston, US-MA, 02210, US
Phone
1-800-FIDELITY
Form
NPORT-P
Filed
September 23, 2026
Report period ends
July 31, 2026
Report month ends
July 31, 2026
Accession number
000003540226006298
Holding Value % of net assets
Fidelity Revere Street Trust STIV $380M 4.31%
Fidelity Revere Street Trust STIV $149M 1.70%
Brightspring Health Services Inc EC $119M 1.36%
Enova International Inc EC $102M 1.15%
Cogent Biosciences Inc EC $97.7M 1.11%
Interdigital Inc EC $90.2M 1.03%
Intapp Inc EC $88.8M 1.01%
Rush Street Interactive Inc EC $76.9M 0.87%
Spyre Therapeutics Inc EC $76.5M 0.87%
Xometry Inc EC $74.1M 0.84%
Oscar Health Inc EC $72.5M 0.82%
Fanatics Inc EC $71.2M 0.81%
Moog Inc EC $70.7M 0.80%
Compass Inc EC $69.4M 0.79%
Enliven Therapeutics Inc EC $68.6M 0.78%
Oruka Therapeutics Inc EC $66.2M 0.75%
Granite Construction Inc EC $65.1M 0.74%
Cheesecake Factory (the) EC $62.6M 0.71%
Ensign Group Inc EC $61M 0.69%
Veeco Instruments Inc EC $60.1M 0.68%
Mirum Pharmaceuticals Inc EC $59.8M 0.68%
Dave Inc EC $59.6M 0.68%
Osi Systems Inc EC $59.1M 0.67%
Jfrog Ltd EC $57.8M 0.66%
Praxis Precision Medicines Inc. EC $57.5M 0.65%
Lifestance Health Group Inc EC $57M 0.65%
Cg Oncology Inc EC $56.8M 0.65%
Frontdoor Inc EC $55.6M 0.63%
Transmedics Group Inc EC $55.6M 0.63%
Maxlinear Inc EC $55.1M 0.63%
Victoria's Secret And Co EC $53.6M 0.61%
Aehr Test Systems EC $52.5M 0.60%
Woodward Inc EC $52.5M 0.60%
Progyny Inc EC $52.2M 0.59%
Blue Bird Corp EC $51.6M 0.59%
Dianthus Therapeutics Inc EC $50.1M 0.57%
Huron Consulting Group Inc EC $49.2M 0.56%
Xenon Pharmaceuticals Inc EC $48.9M 0.56%
Beta Technologies Inc EC $48.8M 0.55%
Adeia Inc EC $48.5M 0.55%
Aci Worldwide Inc EC $48.1M 0.55%
Azz Inc EC $47.9M 0.54%
Sterling Infrastructure Inc EC $47.4M 0.54%
Guardant Health Inc EC $46.5M 0.53%
Workiva Inc EC $45.9M 0.52%
Pinnacle Financial Partners Inc EC $45.2M 0.51%
Vaxcyte Inc EC $45.1M 0.51%
Silicon Motion Tech Corp EC $44.7M 0.51%
Braze Inc EC $44.1M 0.50%
Yeti Holdings Inc EC $44.1M 0.50%
Nextpower Inc EC $43.9M 0.50%
East West Bancorp Inc EC $43.8M 0.50%
Ies Holdings Inc EC $43.6M 0.50%
Kiniksa Pharmaceuticals International PLC EC $43.2M 0.49%
Covista Inc EC $43.1M 0.49%
Amylyx Pharmaceuticals Inc EC $43M 0.49%
Glaukos Corp EC $42.1M 0.48%
Karman Holdings Inc EC $42M 0.48%
Lindblad Expeditions Holdings EC $41.6M 0.47%
Travere Therapeutics Inc EC $41.5M 0.47%

Showing top 60 of 365 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support